140 related articles for article (PubMed ID: 15239655)
1. A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.
Bohl CE; Chang C; Mohler ML; Chen J; Miller DD; Swaan PW; Dalton JT
J Med Chem; 2004 Jul; 47(15):3765-76. PubMed ID: 15239655
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.
Söderholm AA; Lehtovuori PT; Nyrönen TH
J Med Chem; 2005 Feb; 48(4):917-25. PubMed ID: 15715462
[TBL] [Abstract][Full Text] [Related]
3. Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.
Liu H; An X; Li S; Wang Y; Li J; Liu H
Mol Biosyst; 2015 Dec; 11(12):3347-54. PubMed ID: 26442831
[TBL] [Abstract][Full Text] [Related]
4. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT
Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554
[TBL] [Abstract][Full Text] [Related]
5. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor.
Hong H; Fang H; Xie Q; Perkins R; Sheehan DM; Tong W
SAR QSAR Environ Res; 2003; 14(5-6):373-88. PubMed ID: 14758981
[TBL] [Abstract][Full Text] [Related]
6. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional quantitative structure--activity relationships for androgen receptor ligands.
Waller CL; Juma BW; Gray LE; Kelce WR
Toxicol Appl Pharmacol; 1996 Apr; 137(2):219-27. PubMed ID: 8661347
[TBL] [Abstract][Full Text] [Related]
8. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations.
Bisson WH; Abagyan R; Cavasotto CN
J Mol Graph Model; 2008 Nov; 27(4):452-8. PubMed ID: 18805032
[TBL] [Abstract][Full Text] [Related]
10. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
11. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
13. Theoretical studies of QSAR and molecular design on a novel series of ethynyl-3-quinolinecarbonitriles as SRC inhibitors.
Fang DQ; Wu WJ; Zhang R; Zeng GH; Zheng KC
Chem Biol Drug Des; 2012 Jul; 80(1):134-47. PubMed ID: 22429605
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
Nayyar A; Malde A; Jain R; Coutinho E
Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
[TBL] [Abstract][Full Text] [Related]
15. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
16. Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Lill MA; Winiger F; Vedani A; Ernst B
J Med Chem; 2005 Sep; 48(18):5666-74. PubMed ID: 16134935
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Yi P; Fang X; Qiu M
Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
[TBL] [Abstract][Full Text] [Related]
18. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
[TBL] [Abstract][Full Text] [Related]
19. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
20. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]